Corporate Support
Sitemap
Singapore

ShareInvestor.com

Mobile Edition
Mode - Streaming
Switch to Static Mode?

Price Highlight

Index Highlight

Chart
STI
3,111.7
-5.8 (-0.19%)

 

  • STI Straits Times Index
    3,111.7
    -5.8 (-0.19%)
     
  • KLCI FTSE Bursa Malaysia KLCI
    1,505.6
    10.4 (0.70%)
    Index delayed 15 minutes
  • HSI Hang Seng Index
    26,778.6
    82.1 (0.31%)
    Index delayed 15 minutes
  • SSE SSE Composite Index
    2,991.3
    3.4 (0.11%)
    Index delayed 15 minutes
  • N225 Nikkei 225
    21,948.2
    -478.0 (-2.13%)
    Index delayed 20 minutes
  • JCI Jakarta Composite Index
    5,535.7
    -153.2 (-2.69%)
    Index delayed 10 minutes

SGX Market

Bursa Market

HKEx Market

SET Market

IDX Market

ASX Market

NYSE Market

NASDAQ Market

NYSE American Market

  • Volume: 1,186.6M
  • Value: 1,593.1M
  • Rise: 117
  • Fall: 220
  • Unch: 475

Intraday Market Ticker Help

Intraday Market Ticker
Time Name Type Price Vol
  • Top Active

  • Top Gainer

  • Top Loser

Top Counters
Name Last Change
Rex Intl0.199+0.004
Genting Sing0.830-0.010
Singtel3.070-0.010
BreadTalk0.760+0.115
Golden Agri-Res0.205-
Amplefield Ltd0.046+0.002
AusGroup^0.044-
YZJ Shipbldg SGD0.975+0.005
Mapletree Com Tr2.200-0.030
Net Pacific Fin0.025+0.001

World Indices

World Indices
Name Last Change
Nasdaq 8,980.8 +15.2
HSI 26,778.6 +82.1
HSCEI 10,593.1 +91.5
Jakarta 5,535.7 -153.2
Nikkei 225 21,948.2 -478.0
SSE Comp 2,991.3 +3.4
Shanghai A 3,134.7 +3.6
Shanghai B 239.6 -0.7
KOSPI 2,054.9 -21.9

Asian Indices delayed. US Indices updated twice daily at 7:30am and 7:30pm.

Fundamental - Factsheet

Help
  • Factsheet

  • Print

PULMATRIX INCORPORATED PULMATRIX INCORPORATED
Updated on 26 Feb 2020 (End of trading day)
Last (USD): 1.390 Change: - High: 1.430 Remarks: -
Change (%): - Low: 1.350
Open 1.430 Yesterday's Close 1.39
Buy Price - Sell Price -
Buy Volume (share) - Sell Volume (share) -
Cumulative Volume (share) 195,749 Cumulative Value
Click to show Stock Prices chart

Key Statistics

EPS (USD) a -1.02841 Trailing EPS (USD) e -1.04491 NAV (USD) b 0.7365
PE a - Trailing PE f - Price / NAV b 1.8873
Dividend (USD) d - Cash In Hand (USD) g 1.3943 Issued & Paid-up Shares c 19,995,000
Dividend Yield (%) d - Price / Cash In Hand g 0.997 Treasury Shares h -
Beta - 75 Daysi 2.801 R-Squared - 75 Days(%)i 4.81 Market Cap (M) 27.793
Beta - 500 Daysi 1.778 R-Squared - 500 Days (%)i 0.23 Enterprise Value (M) -0.086
Piotroski F Score 2 Exchange Code PULM Par Value ( $ ) n.a.
52 Weeks Volatility (%) 91.33 Free Float (%) 96.3
Sector & Industry Health Technology - Biotechnology
Notes:
  1. Based on latest Full Year results announcement, adjusted for the current number of shares.
  2. Based on latest results announcement (Full Year, Half Year or Interim), adjusted for carrying value of "Other Share Capital", illustrative financial effects of corporate actions (if applicable) and the current number of shares.
  3. Rounded to the nearest thousand. Updated on 05 Nov 2019.Please click here for more information.
  4. Dividend is based on latest Full Year results announcement, adjusted for current number of shares and excludes special dividend.
  5. Summation of the earnings from the latest 4 Quarter (or 2 Half Year) results announcement, adjusted for the current number of shares.
  6. Based on Trailing EPS.
  7. Based on reported cash and cash equivalents at end and extracted from the latest results announcement (Full Year, Half Year or Interim), adjusted for the current number of shares.
  8. Rounded to the nearest thousand. Updated on 29 Jul 2015.
  9. Beta and R-Squared are calculated in relation to the market index using the historical daily closing values of the stock and index as data points.

Peer Comparison

Type Name Market Market Cap (M)a PE b Trailing PE c Price / NAV d Dividend Yield (%)d
Reference PULMATRIX INCORPORATED NASDAQ 27.793 - - 1.8873 -
Industry Biotechnology NASDAQ 2,418.436 283.921 187.446 5.8838 0.754
Local Peer AMGEN INC NASDAQ 126,537.194 15.075 16.136 13.0815 2.627
Local Peer GILEAD SCIENCES INC NASDAQ 94,570.200 17.336 17.559 4.1984 3.091
Local Peer VERTEX PHARMACEUTICAL NASDAQ 60,160.779 28.697 51.122 9.8863 -
Local Peer BIOGEN INC NASDAQ 56,997.257 12.864 9.679 4.2716 -
Local Peer REGENERON PHARMACEUTICALS INC NASDAQ 50,380.345 20.611 23.811 4.5430 -
Local Peer ILLUMINA INC NASDAQ 40,380.900 48.887 40.300 8.7537 -
Local Peer ALEXION PHARMACEUTICAL INC NASDAQ 20,984.387 270.414 8.728 1.8617 -
Local Peer SEATTLE GENETICS INC NASDAQ 19,312.069 - - 10.2927 -
Local Peer INCYTE CORPORATION NASDAQ 16,902.025 154.365 37.820 6.5048 -
Local Peer BIOMARIN PHARMACEUTICAL NASDAQ 16,385.393 - - 5.3296 -
Local Peer GALAPAGOS NV SPON ADR REPR 1 ORD SHS NASDAQ 15,126.258 - 48.738 5.4727 -
Local Peer ALNYLAM PHARMACEUTICALS INC NASDAQ 13,290.541 - - 9.2380 -
Other Local Peers BEIGENE LTD SPON ADS EACH REPR 13 ORD SHS (NASDAQ), EXACT SCIENCES CORP (NASDAQ), MODERNA INC (NASDAQ), NEUROCRINE BIOSCIENCES INC (NASDAQ), SAREPTA THERAPEUTICS INC (NASDAQ), IONIS PHARMACEUTICALS INC (NASDAQ), BIONTECH SE SPON ADS EACH REP 1 ORD SHS (NASDAQ), BIO-TECHNE CORP (NASDAQ), 10X GENOMICS INC (NASDAQ), ASCENDIS PHARMA A/S SPON ADR EACH REP 1 ORD SHS (NASDAQ), ACADIA PHARMACEUTICALS INC (NASDAQ), EXELIXIS INC (NASDAQ), ACCELERON PHARMA (NASDAQ), CHINA BIOLOGIC PRODUCTS HLDGS INC (NASDAQ), ZAI LAB LIMITED ADS EACH REP 1 ORD SHS (NASDAQ), IOVANCE BIOTHERAPEUTICS INC (NASDAQ), BLUEBIRD BIO INC (NASDAQ), GLOBAL BLOOD THERAPEUTICS INC (NASDAQ), VIR BIOTECHNOLOGY INC (NASDAQ), MIRATI THERAPEUTICS INC (NASDAQ), ARROWHEAD PHARMACEUTICALS INC (NASDAQ), FIBROGEN INC (NASDAQ), MORPHOSYS SPON ADS EACH REP 0.25 ORD SHS (NASDAQ), MOMENTA PHARMACEUTICALS INC (NASDAQ), IMMUNOMEDICS INC (NASDAQ), PTC THERAPEUTICS INC (NASDAQ), AGIOS PHARMACEUTICALS INC (NASDAQ), ULTRAGENYX PHARMACEUTICAL INC (NASDAQ), ALKERMES PLC (NASDAQ), BLUEPRINT MEDICINES CORP (NASDAQ), ALLOGENE THERAPEUTICS INC (NASDAQ), CRISPR THERAPEUTICS AG (NASDAQ), DECIPHERA PHARMACEUTICALS INC (NASDAQ), HALOZYME THERAPEUTICS INC (NASDAQ), KODIAK SCIENCES INC (NASDAQ), CHEMOCENTRYX INC (NASDAQ), AMICUS THERAPEUTICS INC (NASDAQ), FATE THERAPEUTICS (NASDAQ), INSMED INC (NASDAQ), ARENA PHARMACEUTICALS INC (NASDAQ), UNIQURE N.V. (NASDAQ), DENALI THERAPEUTICS INC (NASDAQ), VIELA BIO INC (NASDAQ), ALECTOR INC (NASDAQ), EPIZYME INC (NASDAQ), AURINIA PHARMACEUTICALS INC (NASDAQ), ARVINAS INC (NASDAQ), XENCOR INC (NASDAQ), LIGAND PHARMACEUTICAL INC (NASDAQ), EIDOS THERAPEUTICS INC (NASDAQ), REGENXBIO INC (NASDAQ), AIMMUNE THERAPEUTICS INC (NASDAQ), HERON THERAPEUTICS INC (NASDAQ), ESPERION THERAPEUTICS INC (NASDAQ), INTRA-CELLUAR THERAPIES INC (NASDAQ), DICERNA PHARMACEUTICALS INC. (NASDAQ), COHERUS BIOSCIENCES INC (NASDAQ), CORTEXYME INC (NASDAQ), TG THERAPEUTICS INC (NASDAQ), MYRIAD GENETICS INC (NASDAQ), TWIST BIOSCIENCE CORPORATION (NASDAQ), NEXTCURE INC (NASDAQ), BEAM THERAPEUTICS INC (NASDAQ), NGM BIOPHARMACEUTICALS INC (NASDAQ), NANOSTRING TECHNOLOGIES INC (NASDAQ), EDITAS MEDICINE INC (NASDAQ), VERACYTE INC (NASDAQ), ROCKET PHARMACEUTICALS INC (NASDAQ), BLACK DIAMOND THERAPEUTICS INC (NASDAQ), AKEBIA THERAPEUTICS INC (NASDAQ), LUMINEX CORP(DEL) (NASDAQ), DBV TECHNOLOGIES SPON ADR EACH REPR 0.5 ORD (NASDAQ), ENANTA PHARMACEUTICALS INC (NASDAQ), ADVERUM BIOTECHNOLOGIES INC (NASDAQ), AVITA MEDICAL LTD SPON ADS EACH REP 20 ORD SHS (NASDAQ), APPLIED THERAPEUTICS INC (NASDAQ), KARYOPHARM THERAPEUTICS INC (NASDAQ), MESOBLAST LTD SPON ADR EACH REP 5 SHS (NASDAQ), RHYTHM PHARMACEUTICALS INC (NASDAQ), STOKE THERAPEUTICS INC (NASDAQ), CYTOKINETICS INC (NASDAQ), RADIUS HEALTH INC (NASDAQ), IMMUNOGEN INC (NASDAQ), SANGAMO THERAPEUTICS INC (NASDAQ), CARA THERAPEUTICS INC (NASDAQ), FREQUENCY THERAPEUTICS INC (NASDAQ), MOLECULAR TEMPLATES INC (NASDAQ), PRECIGEN INC (NASDAQ), CELLECTIS ADS EACH REPR 1 ORD SPON (NASDAQ), HOMOLOGY MEDICINES INC (NASDAQ), OMEROS CORP (NASDAQ), ZIOPHARM ONCOLOGY INC (NASDAQ), AVROBIO INC (NASDAQ), RETROPHIN INC (NASDAQ), BIOXCEL THERAPEUTICS INC (NASDAQ), RUBIUS THERAPEUTICS INC (NASDAQ), FLEXION THERAPEUTICS INC (NASDAQ), GENFIT SPON ADS EACH REP 1 ORD SHS (NASDAQ), ATARA BIOTHERAPEUTICS INC (NASDAQ), VANDA PHARMACE INC (NASDAQ), MEIRAGTX HOLDINGS PLC (NASDAQ), INTELLIA THERAPEUTICS INC (NASDAQ), UROGEN PHARMA LTD (NASDAQ), INNATE PHARMA SPON ADS EACH REP 1 ORD SHS (NASDAQ), APTOSE BIOSCIENCES INC (NASDAQ), MACROGENICS INC (NASDAQ), ARDELYX INC (NASDAQ), RAPT THERAPEUTICS INC (NASDAQ), REPLIMUNE GROUP INC (NASDAQ), PREVAIL THERAPEUTICS INC (NASDAQ), KURA ONCOLOGY INC (NASDAQ), CLOVIS ONCOLOGY INC (NASDAQ), XBIOTECH INC (NASDAQ), COMPUGEN (NASDAQ), PACIFIC BIOSCIENCES CALIFORNIA INC (NASDAQ), BELLUS HEALTH INC (NASDAQ), AUTOLUS THERAPEUTICS PLC SPON ADS EA REP 1 ORD SHS (NASDAQ), MERUS B V (NASDAQ), NANTKWEST INC (NASDAQ), PROTHENA CORP PLC (NASDAQ), MORPHIC HOLDING INC (NASDAQ), SINOVAC BIOTECH LTD (NASDAQ), MAGENTA THERAPEUTICS INC (NASDAQ), SCHOLAR ROCK HOLDING CORPORATION (NASDAQ), VIKING THERAPEUTICS INC (NASDAQ), ADAPTIMMUNE THERAPEUTICS PLC ADS EACH REPR 6 SHS (SPONS) (NASDAQ), MERSANA THERAPEUTICS INC (NASDAQ), PROGENICS PHARMACEUTICALS INC (NASDAQ), CUE BIOPHARMA INC (NASDAQ), TRANSLATE BIO INC (NASDAQ), ANAPTYSBIO INC (NASDAQ), XENON PHARMACEUTICALS INC (NASDAQ), PUMA BIOTECHNOLOGY INC (NASDAQ), PRECISION BIOSCIENCES INC (NASDAQ), VOYAGER THERAPEUTICS INC (NASDAQ), AGENUS INC (NASDAQ), CABALETTA BIO INC (NASDAQ), SORRENTO THERAPEUTICS INC (NASDAQ), CALITHERA BIOSCIENCES INC (NASDAQ), BIOCRYST PHARMACEUTICALS INC (NASDAQ), PDL BIOPHARMA INC (NASDAQ), CORBUS PHARMACEUTICALS HOLDINGS IN (NASDAQ), PROQR THERAPEUTICS N V (NASDAQ), AVID BIOSERVICES INC (NASDAQ), SELECTA BIOSCIENCES INC (NASDAQ), RIGEL PHARMACEUTICALS INC (NASDAQ), HARPOON THERAPEUTICS INC (NASDAQ), DYNAVAX TECHNOLOGIES CORP (NASDAQ), RECRO PHARMA INC (NASDAQ), CYTOMX THERAPEUTICS INC (NASDAQ), SYNDAX PHARMACEUTICALS INC (NASDAQ), CELLULAR BIOMEDICINE GROUP INC (NASDAQ), CONCERT PHARMACEUTICALS INC (NASDAQ), MERIDIAN BIOSCIENCE INC COM (NASDAQ), STEMLINE THERAPEUTICS INC (NASDAQ), LEXICON PHARMACEUTICALS INC (NASDAQ), NOVAVAX INC (NASDAQ), WAVE LIFE SCIENCES LTD (NASDAQ), MANNKIND CORPORATION (NASDAQ), MINERVA NEUROSCIENCES INC (NASDAQ), BICYCLE THERAPEUTICS PLC SPON ADS EACH REP 1 ORD SHS (NASDAQ), EVOFEM BIOSCIENCES INC (NASDAQ), ADMA BIOLOGICS INC (NASDAQ), ADURO BIOTECH INC (NASDAQ), IVERIC BIO INC (NASDAQ), PERSONALIS INC (NASDAQ), UNITY BIOTECHNOLOGY INC (NASDAQ), KAMADA (NASDAQ), SYROS PHARMACEUTICALS INC (NASDAQ), SPECTRUM PHARMACEUTICALS INC (NASDAQ), TRILLIUM THERAPEUTICS INC (NASDAQ), NEUROBO PHARMACEUTICALS INC (NASDAQ), SERES THERAPEUTICS (NASDAQ), EIGER BIOPHARMACEUTICALS INC (NASDAQ), BIOFRONTERA AG SPON ADS EACH REP TWO ORD SHS (NASDAQ), ANAVEX LIFE SCIENCES CORPORATION (NASDAQ), GERON CORP (NASDAQ), VBI VACCINES INC CDA (NASDAQ), CO DIAGNOSTICS INC (NASDAQ), PROTAGONIST THERAPEUTICS INC (NASDAQ), VTV THERAPEUTICS INC (NASDAQ), LIMINAL BIOSCIENCES INC (NASDAQ), XOMA CORP (NASDAQ), CASI PHARMACEUTICALS INC (NASDAQ), NEPTUNE WELLNESS SOLUTIONS INC (NASDAQ), KEZAR LIFE SCIENCES INC (NASDAQ), MEDICINOVA INC (NASDAQ), ATHERSYS INC (NASDAQ), LA JOLLA PHARMACEUTICAL CO (NASDAQ), PIERIS PHARMACEUTICALS INC (NASDAQ), CHIASMA INC (NASDAQ), AFFIMED N V (NASDAQ), TAIWAN LIPOSOME COMPANY LTD SPON ADS EACH REP 2 ORD SHS (NASDAQ), X4 PHARMACEUTICALS INC (NASDAQ), FIVE PRIME THERAPEUTICS (NASDAQ), JOUNCE THERAPEUTICS INC (NASDAQ), ARBUTUS BIOPHARMA CORP (NASDAQ), BRAINSTROM CELL THERAPEUTICS (NASDAQ), FORTRESS BIOTECH INC (NASDAQ), GLYCOMIMETICS INC (NASDAQ), CONTRAFECT CORP (NASDAQ), VERASTEM INC (NASDAQ), PARATEK PHARMACEUTICALS INC (NASDAQ), DYADIC INTERNATIONAL INC (NASDAQ), STRONGBRIDGE BIOPHARMA PLC (NASDAQ), ELOXX PHARMACEUTICALS INC (NASDAQ), CELYAD ADS EACH REPR 1 ORD (NASDAQ), AXOVANT GENE THERAPIES LTD (NASDAQ), IMV INC (NASDAQ), SIERRA ONCOLOGY INC (NASDAQ), SOLID BIOSCIENCES INC (NASDAQ), ARAVIVE INC (NASDAQ), FENNEC PHARMACEUTICALS INC (NASDAQ), NUCANA PLC SPON ADR EACH REP 1 ORD SHS (NASDAQ), NABRIVA THERAPEUTICS PLC (NASDAQ), INFLARX N V (NASDAQ), GALECTIN THERAPEUTICS INC (NASDAQ), APPLIED GENETIC TECHNOLOGIES CORP (NASDAQ), ERYTECH PHARMA SPON ADR EACH REPR 1 ORD (NASDAQ), EDAP TMS S.A. SPON ADR EACH REPR 1 ORD SHARE (NASDAQ), ALDEYRA THERAPEUTICS (NASDAQ), CHIMERIX INC (NASDAQ), HARVARD BIOSCIENCE INC (NASDAQ), AVALON GLOBOCARE CORP (NASDAQ), VACCINEX INC (NASDAQ), CYMABAY THERAPEUTICS INC (NASDAQ), IMMUTEP LTD SPON ADS EACH REP 10 ORD SHS (NASDAQ), SUNESIS PHARMACEUTICALS INC (NASDAQ), MONOPAR THERAPEUTICS INC (NASDAQ), CATALYST BIOSCIENCES INC (NASDAQ), OTONOMY INC (NASDAQ), CIDARA THERAPEUTICS INC (NASDAQ), SUMMIT THERAPEUTICS PLC ADS EACH REPR 5 ORD (NASDAQ), SAVARA INC (NASDAQ), EQUILLIUM INC (NASDAQ), VERMILLION INC (NASDAQ), AXCELLA HEALTH INC (NASDAQ), CATABASIS PHARMACEUTICALS INC (NASDAQ), PROTEOSTASIS THERAPEUTICS INC (NASDAQ), ANPAC BIO MEDICAL SCIENCE CO LTD SPON ADS EACH REPR 1 ORD SHS CLASS A (NASDAQ), SESEN BIO INC (NASDAQ), AVEO PHARMACEUTICALS INC (NASDAQ), ORGENESIS INC (NASDAQ), VAXART INC (NASDAQ), SURFACE ONCOLOGY INC (NASDAQ), COHBAR INC (NASDAQ), CHAMPIONS ONCOLOGY INC (NASDAQ), SYNLOGIC INC (NASDAQ), ASLAN PHARMACEUTICALS LIMITED ADS EACH REP 5 ORD SHS (NASDAQ), PLURISTEM THERAPEUTICS INC (NASDAQ), INFINITY PHARMACEUTICALS INC (NASDAQ), DIAMEDICA THERAPEUTICS INC (NASDAQ), STEALTH BIOTHERAPEUTICS CORP SPON ADS EACH REP 12 ORD SHS (NASDAQ), MICROBOT MEDICAL INC (NASDAQ), ANIXA BIOSCIENCES INC (NASDAQ), ENTASIS THERAPEUTICS HLDGS INC (NASDAQ), ONCONOVA THERAPEUTICS INC (NASDAQ), LEAP THERAPEUTICS INC (NASDAQ), TREVENA INC (NASDAQ), ACORDA THERAPEUTICS INC (NASDAQ), ONCOLYTICS BIOTECH INC (NASDAQ), ALPINE IMMUNE SCIENCES INC (NASDAQ), AQUABOUNTY TECHNOLOGIES INC (NASDAQ), SOLIGENIX INC (NASDAQ), ADVAXIS INC (NASDAQ), GENOCEA BIOSCIENCES INC (NASDAQ), RESTORBIO INC (NASDAQ), NEWLINK GENETICS CORP (NASDAQ), INMUNE BIO INC (NASDAQ), OPIANT PHARMACEUTICALS INC (NASDAQ), VASCULAR BIOGENICS LTD (NASDAQ), TIZIANA LIFE SCIENCES PLC SPON ADS EACH REPR 10 ORD SHS (NASDAQ), ZAFGEN INC (NASDAQ), NEON THERAPEUTICS INC (NASDAQ), IDERA PHARMACEUTICALS INC (NASDAQ), MEREO BIOPHARMA GROUP PLC SPON ADS EACH REP 5 ORD SHS (NASDAQ), BELLICUM PHARMACEUTICALS (NASDAQ), ITERUM THERAPEUTICS PLC (NASDAQ), FORWARD PHARMA AS SPON ADS EACH REP 14 ORD SHS (NASDAQ), TOCAGEN INC (NASDAQ), MERRIMACK PHARMACEUTICALS INC (NASDAQ), CLEVELAND BIOLABS INC (NASDAQ), CURIS INC (NASDAQ), ORGANOVO HLDGS INC (NASDAQ), MIRAGEN THERAPEUTICS INC (NASDAQ), EVOGENE LTD (NASDAQ), OUTLOOK THERAPEUTICS INC (NASDAQ), ATYR PHARMA INC (NASDAQ), HTG MOLECULAR DIAGNOSTICS INC (NASDAQ), SEELOS THERAPEUTICS INC (NASDAQ), ALIMERA SCIENCES INC (NASDAQ), KAZIA THERAPEUTICS LIMITED SPON ADR EACH REP 10 ORD SHS (NASDAQ), T2 BIOSYSTEMS INC (NASDAQ), VISTAGEN THERAPEUTICS INC (NASDAQ), BIONANO GENOMICS INC (NASDAQ), BIOCARDIA INC (NASDAQ), INNOVATE BIOPHARMACEUTICALS INC (NASDAQ), SOPHIRIS BIO INC (NASDAQ), OCUGEN INC (NASDAQ), AZURRX BIOPHARMA INC (NASDAQ), CELLECTAR BIOSCIENCES INC (NASDAQ), UNUM THERAPEUTICS INC (NASDAQ), APTEVO THERAPEUTICS INC (NASDAQ), AETERNA ZENTARIS INC (NASDAQ), CORREVIO PHARMA CORP (NASDAQ), BIO-PATH HOLDINGS INC (NASDAQ), SELLAS LIFE SCIENCES GROUP INC (NASDAQ), GENETIC TECHNOLOGIES SPON ADS EA REP 600 ORD SHS(R/S) (NASDAQ), MIDATECH PHARMA PLC SPON ADS EACH REP 20 ORD SHS(R/S) (NASDAQ), CONATUS PHARMACEUTICALS INC (NASDAQ), HEAT BIOLOGICS INC (NASDAQ), DIFFUSION PHARMACEUTICALS INC (NASDAQ), TRACON PHARMACEUTICALS INC (NASDAQ), PRECIPIO INC (NASDAQ), CYCLACEL PHARMA IN (NASDAQ), ALTERITY THERAPEUTICS LIMITED SPON ADS EA REPR 60 ORD SHS (NASDAQ), REXAHN PHARMACEUTICALS INC (NASDAQ), ACHIEVE LIFE SCIENCE INC (NASDAQ), ENDRA LIFE SCIENCES INC (NASDAQ), SPHERIX INC (NASDAQ), SENECA BIOPHARMA INC (NASDAQ), ANCHIANO THERAPEUTICS LTD SPON ADS EACH REP 5 ORD SHS (NASDAQ), PLUS THERAPEUTICS INC (NASDAQ), BENITEC BIOPHARMA LTD SPON ADS EA REPR 200 ORD SHS(POST SPLIT) (NASDAQ), XTL BIOPHARMACEUTICALS LTD SPON ADS EACH REP 100 ORD SHS(POST SPLT) (NASDAQ), CELLECT BIOTECHNOLOGY LTD SPON ADS EACH REP 100 ORD SHS(POST SPLT) (NASDAQ), ARCA BIOPHARMA INC (NASDAQ), XENETIC BIOSCIENCES INC (NASDAQ), SENESTECH INC (NASDAQ), CAPRICOR THERAPEUTICS INC (NASDAQ), PHIO PHARMACEUTICALS CORP (NASDAQ), AURIS MEDICAL HOLDING LTD (NASDAQ), INVIVO THERAPEUTICS HOLDING CORP (NASDAQ), THERAPIX BIOSCIENCES LTD SPON ADR EACH REP 40 ORD (POST SPLIT) (NASDAQ)
Global Peer CSL ASX 144,107.535 53.713 49.747 - 0.836
Global Peer AMGEN-T HKEx 589,807.000 8.965 9.598 7.8255 4.417
Global Peer AGILENT TECHNOLOGIES INC NYSE 24,274.088 76.816 31.772 5.0070 0.781
Global Peer WUXI BIO HKEx 147,487.032 197.462 154.371 15.1820 -
Global Peer SINO BIOPHARM HKEx 143,095.592 13.355 13.860 4.2615 0.643
Global Peer BEIGENE HKEx 93,997.029 - - 9.3786 -
Global Peer Lonza SGX 5,937.453 6.613 6.613 0.6568 4.787
Global Peer GENSCRIPT BIO HKEx 31,886.840 191.759 - 8.9920 -
Global Peer EMERGENT BIOSOLUTIONS INC NYSE 3,020.314 48.171 55.317 2.7747 -
Global Peer 3SBIO HKEx 21,386.547 14.137 17.208 2.1079 -
Other Global Peers ALPHAMAB-B (HKEx), HAOHAI BIOTEC (HKEx), FRONTAGE (HKEx), POLYNOVO LIMITED (ASX), MYOVANT SCIENCES LTD (NYSE), AVITA MEDICAL LTD (ASX), VIVA BIOTECH (HKEx), MESOBLAST LTD (ASX), KADMON HLDGS INC (NYSE), ARCUS BIOSCIENCES INC (NYSE), ASCENTAGE-B (HKEx), NANOVIRICIDES INC (NYSE American), ASCLETIS-B (HKEx), SINOMAB BIO-B (HKEx), ESSEX BIO-TECH (HKEx), LEE'S PHARM (HKEx), PFENEX INC (NYSE American), DPHARMA (Bursa), BBI LIFE SCI (HKEx), TELIX PHARMACEUTIC (ASX), NEXT SCIENCE LTD (ASX), LINEAGE CELL THERAPEUTICS INC (NYSE American), NEUREN PHARMACEUTICALS LTD (ASX), UNI-BIO GROUP (HKEx), ENZO BIOCHEM INC (NYSE), IMMUTEP LTD (ASX), CEL-SCI CORP (NYSE American), MATINAS BIOPHARMA HOLDINGS INC (NYSE American), 22ND CENTURY GROUP INC (NYSE American), PALATIN TECHNOLOGIES INC (NYSE American), IMUGENE LIMITED (ASX), CYNATA THERAPEUTICS LTD (ASX), SYNTHETIC BIOLOGICS INC (NYSE American), CT ENTERPRISE (HKEx), BIOTRON (ASX), BIOSINO BIO-TEC (HKEx), INVEX THERAPEUTICS LTD NPV (ASX), ARMATA PHARMACEUTICALS INC (NYSE American), IBIO INC (NYSE American), KAZIA THERAPEUTICS LIMITED (ASX), REGENT PACIFIC (HKEx), MEMPHASYS LTD (ASX), ORAGENICS INC (NYSE American), ANTEOTECH LIMITED (ASX), HOLISTA COLLTECH LIMITED (ASX), CCP TECHNOLOGIES LTD (ASX), GENETIC TECHNOLOGIES (ASX), ACTINOGEN MEDICAL LTD (ASX), ACTINIUM PHARMACEUTICALS INC (NYSE American), BIONOMICS LTD (ASX), RHINOMED LIMITED (ASX), INDIA GLOBALIZATION CAPITAL INC (NYSE American), Suntar Eco-City^ (SGX), CONTANGO ASSET MANAGEMENT LIMITED (ASX), PRESCIENT THERAPEUTICS LIMITED (ASX), REGENEUS LTD (ASX), PATRYS LIMITED (ASX), HAO WEN HLDGS (HKEx), ALTERITY THERAPEUTICS LIMITED (ASX), AIM IMMUNOTECH INC (NYSE American), NOVABAY PHARMACEUTICALS INC (NYSE American), ADALTA LTD (ASX), SIENNA CANCER DIAGNOSTICS LTD (ASX), NEUROSCIENTIFIC BIOPHARMA LTD (ASX), ANATARA LIFESCIENCES LTD (ASX), BENITEC BIOPHARMA LTD (ASX), LIVING CELL TECHNOLOGIES (ASX), CAN FITE BIOPHARMA LTD SPON ADS EA REP 30 ORD SHS(POST REV SPL (NYSE American), AUSTRALIAN PRIMARY HEMP LTD (ASX), LEAF RESOURCES LTD (ASX), AMPLIA THERAPEUTICS LTD (ASX), AVECHO BIOTECHNOLOGY LTD (ASX), NANOLLOSE LTD (ASX), FACTOR THERAPEUTICS LIMITED (ASX), CRYOSITE (ASX)
Notes:
  1. For companies, Market Cap is based on the trading currency of the company. Industry/Index Market Cap is the average market cap for that industry/index.
  2. Industry/Index PE is calculated using (Total Market Cap/Total Earnings) of all companies in the industry/index.
  3. Industry/Index Price/NAV is calculated using (Total Market Cap/Total Shareholders' Equity) of all companies in the industry/index.
  4. Industry/Index Dividend Yield is calculated using (Total Gross Dividend/Total Market Cap) of all companies in the industry/index.
  5. For Industry/Index calculation, data for foreign currency denominated companies will be converted to the main market currency using the latest exchange rate.
  6. Industry/Index/Peers data is updated daily.
  7. Peers are sorted by market capitalisation and only details for the top 10 will be shown.

Total Shareholder Return

PeriodDividend ReceivedCapital AppreciationTotal Shareholder Return
Short Term Return 5 Days --0.190
-12.03 %
10 Days --0.050
-3.47 %
20 Days --0.360
-20.57 %
Medium Term Return 3 Months -+0.572
+69.93 %
6 Months -+0.495
+55.31 %
1 Year -+0.350
+33.65 %
Long Term Return 2 Years --12.710
-90.14 %
3 Years --40.210
-96.66 %
Annualised Return Annualised --
-67.79 %
Notes:
  1. Total Shareholder Return (TSR) combines share price appreciation and dividends paid to show the total return to the shareholder expressed as a percentage.
  2. Script dividends are ignored in this calculation.

Price Movements

1 Year Range 0.610 - 3.010 Change From 1 Year Low +0.780 % Change From 1 Year Low (%) +127.76
Change From 1 Year High -1.620 % Change From 1 Year High (%) -53.82
2 Years Range 0.610 - 15.000 Change From 2 Years Low +0.780 % Change From 2 Years Low (%) +127.76
Change From 2 Years High -13.610 % Change From 2 Years High (%) -90.73
5 Years Range 0.610 - 145.500 Change From 5 Years Low +0.780 % Change From 5 Years Low (%) +127.76
Change From 5 Years High -144.110 % Change From 5 Years High (%) -99.04
Notes:
  1. Price movements are based on adjusted historical data.

Company Background

Pulmatrix, Inc. is a clinical stage biotechnology company, which engages in the discovery and development of novel inhaled therapeutic products. The firm focuses on the prevention and treatment of respiratory diseases and infections. It offers products based on its proprietary dry powder delivery technology, iSPERSE, which enables delivery of small or large molecule drugs to the lungs by inhalation for local or systemic applications. The company was founded by David Alan Edwards, Mark J. Gabrielson, Alexander M. Klibanov and Robert S. Langer, Jr. on June 15, 2015 and is headquartered in Lexington, MA.

Historical Price Data

Date Open High Low Close Volume VWAP
26 Feb 2020 1.430 1.430 1.350 1.390 195,749 -
25 Feb 2020 1.410 1.480 1.250 1.390 481,895 -
24 Feb 2020 1.500 1.500 1.410 1.440 459,540 -
21 Feb 2020 1.580 1.610 1.520 1.540 228,252 -
20 Feb 2020 1.650 1.650 1.520 1.580 217,234 -
19 Feb 2020 1.680 1.680 1.560 1.560 273,481 -
18 Feb 2020 1.540 1.670 1.498 1.650 934,749 -
14 Feb 2020 1.450 1.500 1.390 1.490 276,656 -
13 Feb 2020 1.430 1.480 1.420 1.440 171,360 -
12 Feb 2020 1.430 1.490 1.430 1.440 214,803 -
11 Feb 2020 1.450 1.510 1.400 1.420 817,422 -
10 Feb 2020 1.530 1.590 1.490 1.500 263,793 -
07 Feb 2020 1.620 1.620 1.490 1.530 221,461 -
06 Feb 2020 1.600 1.620 1.480 1.520 475,755 -
05 Feb 2020 1.610 1.650 1.580 1.590 300,403 -
04 Feb 2020 1.650 1.700 1.575 1.610 514,657 -
03 Feb 2020 1.650 1.700 1.650 1.670 368,182 -
31 Jan 2020 1.730 1.750 1.665 1.670 570,217 -
30 Jan 2020 1.880 1.920 1.700 1.750 1,505,431 -
29 Jan 2020 1.770 1.830 1.720 1.820 600,878 -
28 Jan 2020 1.610 1.880 1.610 1.780 1,452,788 -
27 Jan 2020 1.540 1.700 1.510 1.630 613,882 -
Summary
Current 2 Weeks
(12 Feb 2020 to 26 Feb 2020)
1.430 1.680 1.250 1.390 3,453,719 -
Previous 2 Weeks
(29 Jan 2020 to 11 Feb 2020)
1.770 1.830 1.250 1.420 5,638,199 -
4 Weeks from
(30 Dec 2019 to 28 Jan 2020)
0.839 1.680 0.830 1.780 54,906,058 -
View All Historical Data

More Information Available

More information is available to our subscribers, including:

  • Market Moving News from Dow Jones Newswires
  • Consensus Estimates
  • Dividend/Distribution History
  • Financial Summary with Financial Period Comparison
  • Comprehensive Financial Ratios(ROA, ROE, Price/Revenue, Net Earnings Margin, Current Ratio, Debt to Equity Ratio etc)
  • Events Calendar for Results Announcements, Ex-Dates etc
  • Insider Buying and Selling Report

If you are an existing subscriber, please login. If not, read up on what you are missing out in our Help Centre and join us as a subscriber.

Disclaimer:

While reasonable efforts have been taken to ensure that the calculations performed by the features of this site are reliable, the features are provided on the basis that:-

  1. no liability is accepted for any errors or inaccuracies resulting from your use of these features;
  2. many of the data inputs (including share prices) are obtained from third party sources for which we assume no responsibility.